Showing results (281-290 of 500) with videos related to

Sort By:
Pageof 50
Cancer Research|December 17, 2008
Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanomaDavid A Solomon, Jung-Sik Kim, Julia C Cronin, et al.
The Journal of Investigative Dermatology|April 18, 2014
Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formationTodd D Prickett, Brad J Zerlanko, Victoria K Hill, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2017
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell TherapyJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Annals of Surgical Oncology|February 2, 2017
Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma PatientsTristen S Park, Giao Q Phan, James C Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2011
An antigenic peptide produced by reverse splicing and double asparagine deamidationAlexandre Dalet, Paul F Robbins, Vincent Stroobant, et al.
Human Mutation|August 13, 2014
Mutational and functional analysis of the tumor-suppressor PTPRD in human melanomaVijay Walia, Todd D Prickett, Jung-Sik Kim, et al.
Cureus|April 8, 2020
Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based ExperienceAria Shokoohi, Eric Berthelet, Sabrina Gill, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 19, 2020
Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancerSarah Nicole Hamilton, Eric Tran, Cheryl Ho, et al.
Cancer Discovery|June 6, 2019
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal CancersMaria R Parkhurst, Paul F Robbins, Eric Tran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigensRichard A Morgan, Mark E Dudley, Yik Y L Yu, et al.
Pageof 50